Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.
Managing fatigue in patients with multiple sclerosis.
A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone
B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
High-field imaging of neurodegenerative diseases.
Receptos provides update on progress of lead product candidate RPC1063
The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia.
[Diagnosis of multiple sclerosis - the 2010 revision of the McDonald criteria.]
Santhera receives first product approval: Health Canada approves Catena® for treatment of Friedreich's ataxia
Ophthalmic Evaluations in Clinical Studies of Fingolimod (FTY720) in Multiple Sclerosis.
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
The effect of the interval-between-sessions on prefrontal transcranial direct current stimulation (tDCS) on cognitive outcomes: a systematic review and meta-analysis.
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis.
Calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats.
UVB light attenuates the systemic immune response in CNS autoimmunity.
The cost burden of multiple sclerosis in the United States: a systematic review of the literature.
Study Suggests Targeting B Cells May Help with MS
Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
The investigation of acute optic neuritis: a review and proposed protocol.
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis.
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1-images in multiple sclerosis.
Periventricular lesions help differentiate neuromyelitis optica spectrum disorders from multiple sclerosis.
Inhibition of Neuronal Degenerin/Epithelial Na+ Channels by the Multiple Sclerosis Drug 4-Aminopyridine.

Pages